You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

metastatic prostate cancer

Showing 76 - 100 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Hormone Naive Prostate Cancer Trial in Australia (177Lu-PSMA-617, Docetaxel)

Recruiting
  • Metastatic Hormone Naive Prostate Cancer
  • Sydney, New South Wales, Australia
  • +4 more
Nov 4, 2022

Prospective Androgen Receptor Signaling Inhibitors Resistance

Not yet recruiting
  • Prostate Cancer
  • +3 more
    • (no location specified)
    Nov 15, 2023

    Physical Function During ARSI Treatment

    Recruiting
    • Advanced Prostate Carcinoma
    • androgen receptor signaling inhibitors
    • Chapel Hill, North Carolina
      Lineberger Comprehensive Cancer Center at University of North Ca
    Nov 8, 2022

    Prostate Cancer, Prostate Cancer Metastatic Trial in Dallas (68Ga PSMA-11 injection, Positron Emission Tomography/Computed

    Recruiting
    • Prostate Cancer
    • Prostate Cancer Metastatic
    • 68Ga PSMA-11 injection
    • Positron Emission Tomography/Computed Tomography
    • Dallas, Texas
      UT Southwestern Medical Center
    Jan 21, 2022

    Metastatic Prostate Cancer Trial in New York (MR-Guided Prostate SBRT)

    Recruiting
    • Metastatic Prostate Cancer
    • MR-Guided Prostate SBRT
    • New York, New York
      Weill Cornell Medicine
    Oct 29, 2021

    Metastatic Prostate Cancer Trial (Darolutamide, Radium-223)

    Not yet recruiting
    • Metastatic Prostate Cancer
    • (no location specified)
    Mar 6, 2023

    Metastatic Prostate Cancer Trial in Perth (177Lu-DOTA-rosopatamb)

    Not yet recruiting
    • Metastatic Prostate Cancer
    • 177Lu-DOTA-rosopatamb
    • (no location specified)
    Aug 29, 2022

    Metastasis From Malignant Tumor of Prostate (Disorder) Trial in United States (64Cu-PSMA I&T)

    Recruiting
    • Metastasis From Malignant Tumor of Prostate (Disorder)
    • 64Cu-PSMA I&T
    • New Haven, Connecticut
    • +7 more
    Jan 17, 2023

    Metastatic Castration-resistant Prostate Cancer (CRPCa) Trial in France (neuropsychologic evaluation, oncogeriatric evaluation)

    Active, not recruiting
    • Metastatic Castration-resistant Prostate Cancer (CRPCa)
    • neuropsychologic evaluation
    • oncogeriatric evaluation
    • Amiens, France
    • +5 more
    Mar 28, 2022

    Metastatic Castrate-Resistant Prostate Cancer (mCRPC) Trial (TmPSMA-02 CAR T Cells)

    Not yet recruiting
    • Metastatic Castrate-Resistant Prostate Cancer (mCRPC)
    • TmPSMA-02 CAR T Cells
    • (no location specified)
    Sep 13, 2023

    Metastatic Prostate Cancer, Prostate Cancer, Prostate Tumor Trial run by the NCI (M7824, N-803, MVA-BN-Brachyury)

    Recruiting
    • Metastatic Prostate Cancer
    • +4 more
    • M7824
    • +4 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 20, 2023

    Castration Resistant Prostatic Cancer, Metastatic Prostate Cancer Trial in San Francisco (Pembrolizumab, Chemotherapy)

    Active, not recruiting
    • Castration Resistant Prostatic Cancer
    • Metastatic Prostate Cancer
    • San Francisco, California
      University of California, San Francisco
    May 17, 2022

    Advanced Prostate Cancer, Metastatic Prostate Cancer, Locally Advanced Prostate Cancer Trial in China (Triptorelin pamoate

    Recruiting
    • Advanced Prostate Cancer
    • +2 more
    • Triptorelin pamoate (embonate) salt
    • Beijing, China
    • +24 more
    Jan 17, 2023

    Advanced Prostate Cancer Trial (HRS-5041)

    Not yet recruiting
    • Advanced Prostate Cancer
    • (no location specified)
    Jul 5, 2023

    Hormone Sensitive Metastatic Prostate Cancer, DNA Damage Repair Deficiency, Chemo Effect Trial in Nanjing (Docetaxel,

    Recruiting
    • Hormone Sensitive Metastatic Prostate Cancer
    • +3 more
    • Nanjing, Jiangsu, China
      Department of Urology, Drum Tower Hospital, Medical School of Na
    Jul 13, 2022

    Prostate Cancer Metastatic Trial in New York, Knoxville (HB-302/HB-301 Alternating 2-Vector Therapy)

    Recruiting
    • Prostate Cancer Metastatic
    • HB-302/HB-301 Alternating 2-Vector Therapy
    • New York, New York
    • +1 more
    Feb 1, 2023

    Prostate Cancer, Radiotherapy Side Effect, Metastatic Cancer Trial in Umeå (Moderate hypo-fractionation,

    Recruiting
    • Prostate Cancer
    • +2 more
    • Moderate hypo-fractionation
    • Ultra-hypo-fractionation
    • Umeå, Sweden
      Cancercenter University hospital of Umeå
    Nov 1, 2022

    Non-Metastatic Prostate Carcinoma, Stage I Prostate Cancer AJCC v8, Stage II Prostate Cancer AJCC v8 Trial in Los Angeles (7

    Recruiting
    • Non-Metastatic Prostate Carcinoma
    • +9 more
    • 7 Tesla Magnetic Resonance Imaging
    • Los Angeles, California
      USC / Norris Comprehensive Cancer Center
    Aug 6, 2022

    Prostate-Specific Membrane Antigen (PSMA) Radionuclide Therapy

    Recruiting
    • PSMA-positive Metastatic Castration-resistant Prostate Cancer Treated With PSMA Radionuclide Therapy
    • PSMA radionuclide therapy
    • Dallas, Texas
      Methodist Dallas Medical Center
    Aug 9, 2023

    Prostate Cancer Trial in Rotterdam (Adaptive radiotherapy according to UPRATE protocol)

    Recruiting
    • Prostate Cancer
    • Adaptive radiotherapy according to UPRATE protocol
    • Rotterdam, Zuid-Holland, Netherlands
      Erasmus Medical Centre
    Jul 26, 2022

    Metastatic Prostate Cancer Trial in Toronto (Enzalutamide, Standard of Care SBRT and ADT)

    Not yet recruiting
    • Metastatic Prostate Cancer
    • Toronto, Ontario, Canada
      Princess Margaret Cancer Center
    Oct 6, 2022

    Prostate Cancer Trial in Beijing, Nanjing (QLH12016)

    Not yet recruiting
    • Prostate Cancer
    • Beijing, Beijign, China
    • +1 more
    Jul 25, 2023

    Castration-Resistant Prostatic Cancer Trial ([Lu-177]-PNT2002)

    Available
    • Castration-Resistant Prostatic Cancer
    • (no location specified)
    Sep 11, 2023

    Metastatic Castration-resistant Prostate Cancer Trial in United States (BMS-986460)

    Recruiting
    • Metastatic Castration-resistant Prostate Cancer
    • Palo Alto, California
    • +7 more
    Oct 10, 2023

    Stage IV Prostate Adenocarcinoma AJCC v7 Trial in Worldwide (drug, other, procedure)

    Recruiting
    • Stage IV Prostate Adenocarcinoma AJCC v7
    • Antiandrogen Therapy
    • +5 more
    • Duarte, California
    • +15 more
    Jan 24, 2023